APA (7th ed.) Citation

R, Q., S, S., C, S., B, A., C, M., C, C., . . . E, N. (2025). CXCL9 and CXCL10 support the exacerbated humoral response in recovered COVID-19 patients who developed acute respiratory distress syndrome by promoting plasma cell differentiation, whereas CXCL9 also induces CD40L and CXCR3 upregulation on T helper cells. Frontiers in immunology, 16, 1684704. https://doi.org/10.3389/fimmu.2025.1684704

Chicago Style (17th ed.) Citation

R, Quiroga, et al. "CXCL9 and CXCL10 Support the Exacerbated Humoral Response in Recovered COVID-19 Patients Who Developed Acute Respiratory Distress Syndrome by Promoting Plasma Cell Differentiation, Whereas CXCL9 Also Induces CD40L and CXCR3 Upregulation on T Helper Cells." Frontiers in Immunology 16 (2025): 1684704. https://doi.org/10.3389/fimmu.2025.1684704.

MLA (9th ed.) Citation

R, Quiroga, et al. "CXCL9 and CXCL10 Support the Exacerbated Humoral Response in Recovered COVID-19 Patients Who Developed Acute Respiratory Distress Syndrome by Promoting Plasma Cell Differentiation, Whereas CXCL9 Also Induces CD40L and CXCR3 Upregulation on T Helper Cells." Frontiers in Immunology, vol. 16, 2025, p. 1684704, https://doi.org/10.3389/fimmu.2025.1684704.